Targimmune Therapeutics AG
Records under this name other than the patents Targimmune Therapeutics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 3 of 3 · Back to Targimmune Therapeutics AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,230,580 | Chimeric proteins for targeting dsRNA Formerly held Lapsed on the fee record Ended Jan 25, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 25, 2026 | USPTO record |
| US 7,927,792 | Targeted double stranded RNA mediated cell killing Term ended Term ended Mar 26, 2024 · USPTO record | Term ended | Term ended Mar 26, 2024 | USPTO record |
| US 8,372,818 | Targeted double stranded RNA mediated cell killing Term ended Ended no later than Nov 12, 2023 · USPTO record | Term ended | Ended no later than Nov 12, 2023 | USPTO record |